AR077429A1 - HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME - Google Patents

HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME

Info

Publication number
AR077429A1
AR077429A1 ARP100102717A ARP100102717A AR077429A1 AR 077429 A1 AR077429 A1 AR 077429A1 AR P100102717 A ARP100102717 A AR P100102717A AR P100102717 A ARP100102717 A AR P100102717A AR 077429 A1 AR077429 A1 AR 077429A1
Authority
AR
Argentina
Prior art keywords
derivatives
compounds
pharmaceutical compositions
hydroxiasenapina
same
Prior art date
Application number
ARP100102717A
Other languages
Spanish (es)
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of AR077429A1 publication Critical patent/AR077429A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente proporciona compuestos de hidroxiasenapina aislados o purificados, sus derivados, especialmente sus derivados de éster, y composiciones farmacéuticas que comprenden los mismos. La presente proporciona también métodos de tratamiento usando los mismos. Reivindicacion 1: Un compuesto aislado de Formulas 1, 2, o 3; Formula 1, o una sal de la misma; Formula 2, o una sal de la misma, o Formula 3, o una sal de la misma.The present provides isolated or purified hydroxiasenapine compounds, their derivatives, especially their ester derivatives, and pharmaceutical compositions comprising them. This also provides treatment methods using them. Claim 1: An isolated compound of Formulas 1, 2, or 3; Formula 1, or a salt thereof; Formula 2, or a salt thereof, or Formula 3, or a salt thereof.

ARP100102717A 2009-07-29 2010-07-27 HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AR077429A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22956009P 2009-07-29 2009-07-29

Publications (1)

Publication Number Publication Date
AR077429A1 true AR077429A1 (en) 2011-08-24

Family

ID=42734804

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102717A AR077429A1 (en) 2009-07-29 2010-07-27 HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME

Country Status (3)

Country Link
AR (1) AR077429A1 (en)
TW (1) TW201118102A (en)
WO (1) WO2011012654A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566336A (en) * 2016-01-08 2016-05-11 万特制药(海南)有限公司 Novel method for removing methyl impurity in preparation of asenapine
KR102614709B1 (en) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 Transdermal absorption treatment system containing asenapine and polysiloxane or polyisobutylene
CN110087640A (en) 2016-12-20 2019-08-02 罗曼治疗系统股份公司 Transdermal therapeutic system comprising asenapine
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
KR20210022656A (en) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 Transdermal treatment system containing acenapine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (en) 1976-05-24 1977-11-28 Akzo Nv NEW TETRACYCLICAL DERIVATIVES.
DE122010000050I2 (en) 1994-03-02 2011-07-21 Organon Nv Sublingual or buccal medicine.
KR20070084123A (en) 2004-10-15 2007-08-24 엔.브이.오가논 Treatment of bipolar disorders and associated symptoms

Also Published As

Publication number Publication date
TW201118102A (en) 2011-06-01
WO2011012654A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
CY1119784T1 (en) ACUTYLIED SALICYLIC ACID COMPOUNDS AND THEIR USES
CO6480927A2 (en) DERIVATIVES OF IMIDAZOLIN-2-ONA 1,3-DISUSTITUTED AS CYP17 INHIBITORS.
CL2012001911A1 (en) Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.
CO6531452A2 (en) SUBSTITUTED PIPERIDINS THAT INCREASE THE ACTIVITY OF P53 AND ITS USES
UY29360A1 (en) NEW DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS.
UY30498A1 (en) NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
EA201390908A1 (en) DERIVATIVES OF BICYCLO [3.2.1] OCTYLAMIDE AND THEIR APPLICATION
AR062211A1 (en) DERIVATIVES OF 6-CARBOXI-NORMORFINANO. PHARMACEUTICAL COMPOSITIONS
RS53617B1 (en) Novel compound useful for the treatment of degenerative and inflammatory diseases
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
UY32490A (en) BETA-SECRETASA INHIBITORS
ECSP10010722A (en) ORGANIC COMPOUNDS
CO6321248A2 (en) USEFUL TRIAZOL DERIVATIVES FOR THE TREATMENT OF DISEASES
AR056873A1 (en) DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS QUINASA INHIBITORS OF CYCLINE DEPENDENTS, PHARMACEUTICAL COMPOSITIONS
CY1115262T1 (en) TRPV1 COMPETITORS AND THEIR USES
CL2013002417A1 (en) Compounds derived from fluoropyridinone; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
UY31906A (en) DERIVATIVES OF N-CICLOALQUIL-3-PHENYLNICOTINAMIDE INHIBITING PGDS, ITS COMPOSITIONS, ITS USE FOR THE TREATMENT FOR EXAMPLE OF ALLERGIC AND RESPIRATORY AFFECTIONS.
UY33380A (en) PHARMACEUTICAL FORMULATIONS CONTAINING DERIVATIVES OF 1- (B (BETA) -D-GLUCOPIRANOSILO) AND ITS USES
UY31885A (en) DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS.
UY32704A (en) COMPOUNDS OF 2,3-DIHIDRO-1H-INDENO
DOP2011000134A (en) WE REACT AS BETA SECRETASA INHIBITORS
EA200900631A1 (en) SUBSTITUTED PYRAZOLES AND TRIAZOLES AS KIBB INHIBITORS (KYNESIN-PROTEIN VERETEN)
AR079050A1 (en) BENZOIMIDAZOLIC COMPOUNDS AND THEIR USES
CR20190236A (en) Therapeutic compounds and methods of use thereof
AR077429A1 (en) HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME

Legal Events

Date Code Title Description
FA Abandonment or withdrawal